PlainRecalls
FDA Drug Critical Class I Terminated

Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USP, NDC 0409-1559-10.

Reported: June 11, 2014 Initiated: April 21, 2014 #D-1358-2014

Product Description

Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USP, NDC 0409-1559-10.

Reason for Recall

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Details

Recalling Firm
Hospira Inc.
Units Affected
85,680 vials
Distribution
Nationwide.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USP, NDC 0409-1559-10.. Recalled by Hospira Inc.. Units affected: 85,680 vials.
Why was this product recalled?
Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 11, 2014. Severity: Critical. Recall number: D-1358-2014.